Neuro-Oncology Reviews
Volume
26 Number 20
20 September 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 20, 20 September
Cohen
KJ,
et al, PDQ Pediatric Treatment Editorial Board.
Childhood
Medulloblastoma and Other
Central
Nervous System Embryonal Tumors Treatment (PDQ®): Health
Professional
Version.
PDQ
Cancer Inf Summ.
2024 Sep 11. NCBI
Bookshelf ID:
NBK65981.
PMID:
26389418.
Review.
ˍ
Baek C, Laurenge A, Touat M.
Advances
in the treatment of IDH-mutant gliomas.
Curr
Opin Neurol. 2024 Sep 12. doi:
10.1097/WCO.0000000000001316. PMID:
39253756. Review. ˍ
Dai ZY, Jiang Y, Wang FQ, Wang Y.
Primary
pulmonary meningioma: A case report and review of the literature.
Asian
J Surg. 2024 Sep 12:S1015-9584(24)01992-4. doi:
10.1016/j.asjsur.2024.09.007. PMID:
39271347. Case report; Review. ˍ
Lazarev S, Sindhu KK.
Vorasidenib: a
new hope or a false promise for patients with low-grade glioma?
Nat
Rev Clin Oncol. 2024 Sep 12. doi:
10.1038/s41571-024-00944-5. PMID:
39266767. Perspective˰
ˍ
Leili FR, Shali N, Sheibani M, Jafarian MJ, Pashizeh F, Gerami R,
Iraj F, Lashkarshekan AA.
Detailed
pathological role of non-coding RNAs (ncRNAs) in regulating drug
resistance of glioblastoma, and update.
Pathol
Res Pract. 2024 Sep 12;263:155590. doi:
10.1016/j.prp.2024.155590. PMID:
39326365. Review˰ ˍ
Fukushima CM, de Groot J.
Updates for
newly diagnosed and recurrent glioblastoma: a review of recent
clinical trials.
Curr
Opin Neurol. 2024 Sep 13. doi:
10.1097/WCO.0000000000001320. PMID:
39258745. Review. ˍ
Gal O, Mehta MP, Kotecha R.
Radiotherapeutic
advances in the management of glioblastoma.
J
Neurooncol. 2024 Sep 13. doi:
10.1007/s11060-024-04824-x. PMID:
39269554. Review˰ ˍ
Inocencio JF, Mitrasinovic S, Asad M, Parney IF, Zang X, Himes BT.
Immune checkpoint pathways in
glioblastoma: a diverse and evolving landscape.
Front
Immunol. 2024 Sep 13;15:1424396. doi:
10.3389/fimmu.2024.1424396. PMID:
39346924. Review. ˍ
Chellapandian H, Jeyachandran S.
Letter
to Editor, "The effects of dabrafenib and/or trametinib
treatment in Braf V600mutant glioma: a systematic review and
metaanalysis".
Neurosurg
Rev. 2024 Sep 14;47(1):613. doi:
10.1007/s10143-024-02858-3. PMID:
39271502. Review; Meta-analysis˰
ˍ
Palavani LB, Verly G, Borges P, Neto L, Almeida M, Leite M,
Oliveira LB, Batista S, Bertani R, Polverini AD, de Macedo Filho
L, Paiva W.
Beyond surgical resection:
evaluating stereotactic brachytherapy iodine-125 for low-grade
gliomas: a systematic review and meta-analysis.
Neurosurg
Rev. 2024 Sep 14;47(1):617. doi:
10.1007/s10143-024-02839-6. PMID:
39276262. Review; Meta-analysis˰
ˍ
Sipos D, Debreczeni-Máté Z, Ritter Z, Freihat O,
Simon M, Kovács Á.
Complex
Diagnostic Challenges in Glioblastoma: The Role of 18F-FDOPA
PET Imaging.
Pharmaceuticals
(Basel). 2024 Sep 15;17(9):1215. doi:
10.3390/ph17091215. PMID:
39338377. Review. ˍ
Ma Y, Huang Y, Hu F, Shu K.
Lipid
metabolic rewiring in glioma-associated microglia/macrophages
(Review).
Int
J Mol Med. 2024 Sep 16;54(5):102. doi:
10.3892/ijmm.2024.5426. PMID:
39301636. Review. ˍ
Cooksey LC, Friesen DC, Mangan ED, Mathew PA.
Prospective
Molecular Targets for Natural Killer Cell Immunotherapy against
Glioblastoma Multiforme.
Cells.
2024 Sep 17;13(18):1567. doi:
10.3390/cells13181567. PMID:
39329751. Review. ˍ
Almasi F, Nemati M, Aminianfar A.
Dietary
Recommendations for Glioma: A Mini-Review.
Curr
Nutr Rep. 2024 Sep 18. doi:
10.1007/s13668-024-00577-1. PMID:
39292335. Review˰ ˍ
Robert JA, Leclerc A, Ducloie M, Emery E, Agostini D, Vigne J.
Contribution of [18F]FET
PET in the Management of Gliomas, from Diagnosis to Follow-Up: A
Review.
Pharmaceuticals
(Basel). 2024 Sep 18;17(9):1228. doi:
10.3390/ph17091228. PMID:
39338390. Review. ˍ
Cortes Ballen AI, Amosu M, Ravinder S, Chan J, Derin E, Slika H,
Tyler B.
Metabolic Reprogramming in
Glioblastoma Multiforme: A Review of Pathways and Therapeutic
Targets.
Cells.
2024 Sep 19;13(18):1574. doi:
10.3390/cells13181574. PMID:
39329757. Review. ˍ
Manescu Paltanea V, Antoniac I, Paltanea G, Nemoianu IV, Mohan AG,
Antoniac A, Rau JV, Laptoiu SA, Mihai P, Gavrila H, Al-Moushaly
AR, Bodog AD.
Magnetic Hyperthermia in
Glioblastoma Multiforme Treatment.
Int
J Mol Sci. 2024 Sep 19;25(18):10065. doi:
10.3390/ijms251810065. PMID:
39337552. Review. ˍ
Qin Z, Bian XW, Shi Y.
Identification
of hypoxic macrophages in glioblastoma: Unveiling therapeutic
insights from tumour microenvironment analysis.
Clin
Transl Med. 2024 Sep 19;14(9):e70013. doi:
10.1002/ctm2.70013. PMID:
39297872. Editorial. ˍ
Sterner RC, Sterner RM.
EGFRVIII and
EGFR targeted chimeric antigen receptor T cell therapy in
glioblastoma.
Front
Oncol. 2024 Sep 19;14:1434495. doi:
10.3389/fonc.2024.1434495. PMID:
39364321. Review. ˍ
Strika Z, Petković K, Likić R.
Effectiveness
and Safety of mRNA Vaccines in the Therapy of Glioblastoma.
J
Pers Med. 2024 Sep 19;14(9):993. doi:
10.3390/jpm14090993. PMID:
39338247. Perspective. ˍ
Adegboyega G, Momin S, Gillespie CS, Jeelani NUO, Sudhakar S,
Mankad K, Tisdall MM, Aquilina K, Toescu SM.
Intraoperative
MRI in pediatric epilepsy and neuro-oncology: a systematic review
and meta-analysis.
J
Neurosurg Pediatr. 2024 Sep 20:1-14. doi:
10.3171/2024.6.PEDS2414. PMID:
39303299. Review; Meta-analysis˰
ˍ
Bondarev AD, Jonsson J, Chubarev VN, Tarasov VV, Lagunas-Rangel
FA, Schiöth HB.
Recent
developments of topoisomerase inhibitors: Clinical trials,
emerging indications, novel molecules and global sales.
Pharmacol
Res. 2024 Sep 20:107431. doi:
10.1016/j.phrs.2024.107431. PMID:
39307213. Review. ˍ
Debreczeni-Máté Z, Freihat O, Törő I,
Simon M, Kovács Á, Sipos D.
Value
of 11C-Methionine PET Imaging in High-Grade Gliomas: A Narrative
Review.
Cancers
(Basel). 2024 Sep 20;16(18):3200. doi:
10.3390/cancers16183200. PMID:
39335171. Review. ˍ
Ijaz M, Ullah Z, Aslam B, Khurshid M, Chen P, Guo B.
From
promise to progress: the dynamic landscape of glioblastoma
immunotherapy.
Drug
Discov Today. 2024 Sep 20;29(11):104188. doi:
10.1016/j.drudis.2024.104188. PMID:
39307298. Review˰ ˍ
Nakhate V, Lasica AB, Wen PY.
The Role
of Mutant IDH Inhibitors in the Treatment of Glioma.
Curr
Neurol Neurosci Rep. 2024 Sep 20. doi:
10.1007/s11910-024-01378-3. PMID:
39302605. Review˰ ˍ